Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.74 |
| ▸ | SQLE | Q14534 | 6/20 | 0.52 |
| ▸ | ICMT | O60725 | 1/20 | 0.47 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15361567 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL31312707 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL7116219 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL30170465 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL10323892 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL4389533 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3084544 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL900303 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL11042453 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL17953126 | 1.00 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218111-A1 | EPOXY RESIN WITH IMPROVED WATER RESISTANCE AND COMPOSITION COMPRISING SAME | SAMYANG CORPORATION (KR) | 2024-07-04 | — | — | US | claimed |
| CN-117838801-A | Orchid composite extract and its use in preparing composition with anti-depression effect | 福建农林大学 | 2024-04-09 | — | — | CN | claimed |
| EP-4332141-A1 | EPOXY RESIN WITH IMPROVED WATER RESISTANCE AND COMPOSITION COMPRISING SAME | Samyang Corporation (KR) | 2024-03-06 | — | — | EP | claimed |
| WO-2022231233-A1 | EPOXY RESIN WITH IMPROVED WATER RESISTANCE AND COMPOSITION COMPRISING SAME | 주식회사 삼양사 | 2022-11-03 | — | — | WO | claimed |
| EP-2621990-B1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | BLUE CUBE IP LLC (US) | 2016-02-24 | — | — | EP | claimed |
| EP-2621991-B1 | PROCESS FOR PREPARING EPOXY RESINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-07-01 | — | — | EP | claimed |
| US-8962792-B2 | Process for preparing epoxy resins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-24 | — | — | US | claimed |
| US-20140194554-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-10 | — | — | US | claimed |
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | UCB PHARMA S.A. (BE) | 2013-11-14 | — | — | US | claimed |
| US-20130237642-A1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-09-12 | — | — | US | claimed |
| EP-2621994-A1 | EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | claimed |
| EP-2621990-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | claimed |
| EP-2621991-A1 | PROCESS FOR PREPARING EPOXY RESINS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | claimed |
| US-20130178601-A1 | PROCESS FOR PREPARING EPOXY RESINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | claimed |
| WO-2012047420-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | WO | claimed |
| WO-2012044442-A1 | PROCESS FOR PREPARING EPOXY RESINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | claimed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | claimed |
| US-4107219-A | OXIDIZING UNSATURATED AMINE, THERMAL REARRANGEMENT TO FORM UNSATURATED HYDROXYLAMINE, HYDROGENATION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| CN-120193024-A | Use of enzymes for catalyzing geraniol to produce 8-hydroxygeraniol | 深圳华大生命科学研究院 | 2025-06-24 | — | — | CN | disclosed |
| US-4107219-A | OXIDIZING UNSATURATED AMINE, THERMAL REARRANGEMENT TO FORM UNSATURATED HYDROXYLAMINE, HYDROGENATION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | EED, DRD2, PSMD14 | KMT2A 2432/4885MAPT 3809/4885MEN1 4800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.